Literature DB >> 12763690

Bacillus spores for vaccine delivery.

Marco R Oggioni1, Annalisa Ciabattini, Anna M Cuppone, Gianni Pozzi.   

Abstract

Spores of the genus Bacillus have been used for a long time as probiotics for oral bacteriotherapy both in humans and in animals. Spores are also employed in a veterinary vaccine against anthrax. Despite this long lasting and extensive use, the specific contribution of spores to the beneficial effects of probiotics and to the immunogenicity of the vaccine is not completely elucidated. This review focuses on the different aspects of the use of spore preparations. In particular the use of recombinant spores as vaccine delivery vehicles is described and discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763690     DOI: 10.1016/s0264-410x(03)00207-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Display of proteins on Bacillus subtilis endospores.

Authors:  Junehyung Kim; Wolfgang Schumann
Journal:  Cell Mol Life Sci       Date:  2009-06-25       Impact factor: 9.261

Review 2.  Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.

Authors:  Hellen Amuguni; Saul Tzipori
Journal:  Hum Vaccin Immunother       Date:  2012-06-15       Impact factor: 3.452

3.  Display of human proinsulin on the Bacillus subtilis spore surface for oral administration.

Authors:  Fan Feng; Ping Hu; Liang Chen; Qi Tang; Chaoqun Lian; Qin Yao; Keping Chen
Journal:  Curr Microbiol       Date:  2013-02-05       Impact factor: 2.188

4.  Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.

Authors:  Amir Ghaemi; Hoorieh Soleimanjahi; Pooria Gill; Zuhair Hassan; Soodeh Razeghi M Jahromi; Farzin Roohvand
Journal:  Genet Vaccines Ther       Date:  2010-05-12

5.  Probiotic Bacillus amyloliquefaciens SC06 Prevents Bacterial Translocation in Weaned Mice.

Authors:  Jian Ji; Shenglan Hu; Weifen Li
Journal:  Indian J Microbiol       Date:  2013-03-16       Impact factor: 2.461

6.  Characterization of Bacillus probiotics available for human use.

Authors:  Le H Duc; Huynh A Hong; Teresa M Barbosa; Adriano O Henriques; Simon M Cutting
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

7.  Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis.

Authors:  Tran H Hoang; Huynh A Hong; Graeme C Clark; Richard W Titball; Simon M Cutting
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

8.  Development of a Bacillus subtilis-based rotavirus vaccine.

Authors:  Sangun Lee; Boris R Belitsky; James P Brinker; Kathryn O Kerstein; David W Brown; John D Clements; Gerald T Keusch; Saul Tzipori; Abraham L Sonenshein; John E Herrmann
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

9.  Overproduction of Bacillus amyloliquefaciens extracellular glutamyl-endopeptidase as a result of ectopic multi-copy insertion of an efficiently-expressed mpr gene into the Bacillus subtilis chromosome.

Authors:  Yurgis Av Yomantas; Elena G Abalakina; Lyubov I Golubeva; Lyubov Y Gorbacheva; Sergey V Mashko
Journal:  Microb Cell Fact       Date:  2011-08-05       Impact factor: 5.328

10.  Display of Bombyx mori alcohol dehydrogenases on the Bacillus subtilis spore surface to enhance enzymatic activity under adverse conditions.

Authors:  Nan Wang; Cheng Chang; Qin Yao; Guohui Li; Lvgao Qin; Liang Chen; Keping Chen
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.